Fingerprint
Dive into the research topics of 'Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count
Claus Bachert, Ana R. Sousa, Joseph K. Han, Rodney J. Schlosser, Leigh J. Sowerby, Claire Hopkins, Jorge F. Maspero, Steven G. Smith, Oliver Kante, Despina E. Karidi-Andrioti, Bhabita Mayer, Robert H. Chan, Steve W. Yancey, Adam M. Chaker*
*Corresponding author for this work
- Ghent University Hospital
- Stockholm University
- Sun Yat-sen University
- GSK GlaxoSmithKline Research & Development Ltd
- Eastern Virginia Medical School
- Medical University of South Carolina
- University of Western Ontario
- ENT Department
- GSTT Guy's and St Thomas' NHS Foundation Trust
- Fundación CIDEA
- Department of Pharmacology
- Global Clinical Sciences and Delivery
- Technical University of Munich
Research output: Contribution to journal › Article › peer-review
36
Citations
(Scopus)